CONMED CORP (CNMD) Stock News
NYSE:CNMD - New York Stock Exchange, Inc. - US2074101013 - Common Stock - Currency: USD
CNMD Latest News, Press Relases and Analysis
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Over the last six months, CONMED shares have sunk to $51.84, producing a disappointing 19.7% loss - worse than the S&P 500’s 7.3% drop. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Mentions: TDG
CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst performers in the surgical equipment & consumables - diversified industry.
CONMED Corporation Adds Mark Kaye to its Board of Directors
CONMED Corporation Announces Quarterly Cash Dividend
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20
CONMED Corporation Announces Third Quarter 2024 Financial Results
CONMED Corporation Announces Leadership Succession
